Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Sep 20, 2023
- Accession no.
- 0001493152-23-033155
- Filed
- Sep 20, 2023, 12:21 PM ET
- Trade date
- Sep 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.73K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $0.2365 | +$4,730 | 1,533,949 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.